en.unionpedia.org

Adrenergic blocking agent, the Glossary

Adrenergic blocking agents are a class of drugs that exhibit its pharmacological action through inhibiting the action of the sympathetic nervous system in the body.^[1]

163 relations: Abdominal pain, ACE inhibitor, Adenosine triphosphate, Adenylyl cyclase, Adipose tissue, Adrenaline, Adrenergic receptor, Agonist, Airway resistance, Alfuzosin, Alpha blocker, Alpha-1 adrenergic receptor, Alpha-1 blocker, Alpha-2 adrenergic receptor, Alpha-2 blocker, Amnesia, Anesthesia, Angina, Angiotensin, Antidote, Antihypertensive drug, Anxiety, Arrhythmia, Arteriole, Asthma, Atenolol, Atrial fibrillation, Atrioventricular nodal branch, Autonomic nervous system, Benign prostatic hyperplasia, Beta blocker, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-3 adrenergic receptor, Bladder, Blood plasma, Blood pressure, Blood vessel, Blood volume, Bradycardia, Brain injury, Bronchoconstriction, Bronchopulmonary segment, Butaxamine, Calcium channel blocker, Calcium in biology, Cardiac output, Cardiac physiology, Cardiovascular disease, Central nervous system, ... Expand index (113 more) »
Adrenergic receptors
Autonomic nervous system
Drugs by mechanism of action
Sympathetic nervous system

Abdominal pain

Abdominal pain, also known as a stomach ache, is a symptom associated with both non-serious and serious medical issues.

See Adrenergic blocking agent and Abdominal pain

ACE inhibitor

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a class of medication used primarily for the treatment of high blood pressure and heart failure.

See Adrenergic blocking agent and ACE inhibitor

Adenosine triphosphate

Adenosine triphosphate (ATP) is a nucleotide that provides energy to drive and support many processes in living cells, such as muscle contraction, nerve impulse propagation, and chemical synthesis.

See Adrenergic blocking agent and Adenosine triphosphate

Adenylate cyclase (EC 4.6.1.1, also commonly known as adenyl cyclase and adenylyl cyclase, abbreviated AC) is an enzyme with systematic name ATP diphosphate-lyase (cyclizing; 3′,5′-cyclic-AMP-forming).

See Adrenergic blocking agent and Adenylyl cyclase

Adipose tissue

Adipose tissue (also known as body fat or simply fat) is a loose connective tissue composed mostly of adipocytes.

See Adrenergic blocking agent and Adipose tissue

Adrenaline

Adrenaline, also known as epinephrine, is a hormone and medication which is involved in regulating visceral functions (e.g., respiration).

See Adrenergic blocking agent and Adrenaline

Adrenergic receptor

The adrenergic receptors or adrenoceptors are a class of G protein-coupled receptors that are targets of many catecholamines like norepinephrine (noradrenaline) and epinephrine (adrenaline) produced by the body, but also many medications like beta blockers, beta-2 (β2) agonists and alpha-2 (α2) agonists, which are used to treat high blood pressure and asthma, for example. Adrenergic blocking agent and adrenergic receptor are adrenergic receptors.

See Adrenergic blocking agent and Adrenergic receptor

Agonist

An agonist is a chemical that activates a receptor to produce a biological response.

See Adrenergic blocking agent and Agonist

Airway resistance

In respiratory physiology, airway resistance is the resistance of the respiratory tract to airflow during inhalation and exhalation.

See Adrenergic blocking agent and Airway resistance

Alfuzosin

Alfuzosin, sold under the brand name Uroxatral among others, is a medication of the α1 blocker class.

See Adrenergic blocking agent and Alfuzosin

Alpha blocker

Alpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).

See Adrenergic blocking agent and Alpha blocker

Alpha-1 adrenergic receptor

alpha-1 (α1) adrenergic receptors are G protein-coupled receptors (GPCRs) associated with the Gq heterotrimeric G protein. Adrenergic blocking agent and Alpha-1 adrenergic receptor are adrenergic receptors.

See Adrenergic blocking agent and Alpha-1 adrenergic receptor

Alpha-1 blocker

Alpha-1 blockers (also called alpha-adrenergic blocking agents or alpha-1 antagonists) constitute a variety of drugs that block the effect of catecholamines on alpha-1-adrenergic receptors.

See Adrenergic blocking agent and Alpha-1 blocker

Alpha-2 adrenergic receptor

The alpha-2 (α2) adrenergic receptor (or adrenoceptor) is a G protein-coupled receptor (GPCR) associated with the Gi heterotrimeric G-protein. Adrenergic blocking agent and alpha-2 adrenergic receptor are adrenergic receptors.

See Adrenergic blocking agent and Alpha-2 adrenergic receptor

Alpha-2 blocker

Alpha-2 blockers (or α2 blockers) are a subset of the alpha blocker class of drugs and are antagonists to the α2 adrenergic receptor.

See Adrenergic blocking agent and Alpha-2 blocker

Amnesia

Amnesia is a deficit in memory caused by brain damage or brain diseases,Gazzaniga, M., Ivry, R., & Mangun, G. (2009) Cognitive Neuroscience: The biology of the mind.

See Adrenergic blocking agent and Amnesia

Anesthesia

Anesthesia or anaesthesia is a state of controlled, temporary loss of sensation or awareness that is induced for medical or veterinary purposes.

See Adrenergic blocking agent and Anesthesia

Angina

Angina, also known as angina pectoris, is chest pain or pressure, usually caused by insufficient blood flow to the heart muscle (myocardium).

See Adrenergic blocking agent and Angina

Angiotensin

Angiotensin is a peptide hormone that causes vasoconstriction and an increase in blood pressure.

See Adrenergic blocking agent and Angiotensin

Antidote

An antidote is a substance that can counteract a form of poisoning.

See Adrenergic blocking agent and Antidote

Antihypertensive drug

Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure).

See Adrenergic blocking agent and Antihypertensive drug

Anxiety

Anxiety is an emotion which is characterised by an unpleasant state of inner turmoil and includes feelings of dread over anticipated events.

See Adrenergic blocking agent and Anxiety

Arrhythmia

Arrhythmias, also known as cardiac arrhythmias, are irregularities in the heartbeat, including when it is too fast or too slow.

See Adrenergic blocking agent and Arrhythmia

Arteriole

An arteriole is a small-diameter blood vessel in the microcirculation that extends and branches out from an artery and leads to capillaries.

See Adrenergic blocking agent and Arteriole

Asthma

Asthma is a long-term inflammatory disease of the airways of the lungs.

See Adrenergic blocking agent and Asthma

Atenolol

Atenolol is a beta blocker medication primarily used to treat high blood pressure and heart-associated chest pain.

See Adrenergic blocking agent and Atenolol

Atrial fibrillation

Atrial fibrillation (AF, AFib or A-fib) is an abnormal heart rhythm (arrhythmia) characterized by rapid and irregular beating of the atrial chambers of the heart.

See Adrenergic blocking agent and Atrial fibrillation

Atrioventricular nodal branch

The atrioventricular nodal branch is a coronary artery that supplies arterial blood to the atrioventricular node, which is responsible for initiating muscular contraction of the ventricles.

See Adrenergic blocking agent and Atrioventricular nodal branch

Autonomic nervous system

The autonomic nervous system (ANS), sometimes called the visceral nervous system and formerly the vegetative nervous system, is a division of the nervous system that operates internal organs, smooth muscle and glands.

See Adrenergic blocking agent and Autonomic nervous system

Benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland.

See Adrenergic blocking agent and Benign prostatic hyperplasia

Beta blocker

Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage abnormal heart rhythms (arrhythmia), and to protect the heart from a second heart attack after a first heart attack (secondary prevention).

See Adrenergic blocking agent and Beta blocker

Beta-1 adrenergic receptor

The beta-1 adrenergic receptor (β1 adrenoceptor), also known as ADRB1, can refer to either the protein-encoding gene (gene ADRB1) or one of the four adrenergic receptors. Adrenergic blocking agent and beta-1 adrenergic receptor are adrenergic receptors.

See Adrenergic blocking agent and Beta-1 adrenergic receptor

Beta-2 adrenergic receptor

The beta-2 adrenergic receptor (β2 adrenoreceptor), also known as ADRB2, is a cell membrane-spanning beta-adrenergic receptor that binds epinephrine (adrenaline), a hormone and neurotransmitter whose signaling, via adenylate cyclase stimulation through trimeric Gs proteins, increases cAMP, and, via downstream L-type calcium channel interaction, mediates physiologic responses such as smooth muscle relaxation and bronchodilation. Adrenergic blocking agent and beta-2 adrenergic receptor are adrenergic receptors.

See Adrenergic blocking agent and Beta-2 adrenergic receptor

Beta-3 adrenergic receptor

The beta-3 adrenergic receptor (β3-adrenoceptor), also known as ADRB3, is a beta-adrenergic receptor, and also denotes the human gene encoding it. Adrenergic blocking agent and beta-3 adrenergic receptor are adrenergic receptors.

See Adrenergic blocking agent and Beta-3 adrenergic receptor

Bladder

The bladder is a hollow organ in humans and other vertebrates that stores urine from the kidneys before disposal by urination.

See Adrenergic blocking agent and Bladder

Blood plasma

Blood plasma is a light amber-colored liquid component of blood in which blood cells are absent, but which contains proteins and other constituents of whole blood in suspension.

See Adrenergic blocking agent and Blood plasma

Blood pressure

Blood pressure (BP) is the pressure of circulating blood against the walls of blood vessels.

See Adrenergic blocking agent and Blood pressure

Blood vessel

Blood vessels are the structures of the circulatory system that transport blood throughout the human body.

See Adrenergic blocking agent and Blood vessel

Blood volume

Blood volume (volemia) is the volume of blood (blood cells and plasma) in the circulatory system of any individual.

See Adrenergic blocking agent and Blood volume

Bradycardia

Bradycardia, also called bradyarrhythmia, is a resting heart rate under 60 beats per minute (BPM).

See Adrenergic blocking agent and Bradycardia

Brain injury

Brain injury (BI) is the destruction or degeneration of brain cells.

See Adrenergic blocking agent and Brain injury

Bronchoconstriction

Bronchoconstriction is the constriction of the airways in the lungs due to the tightening of surrounding smooth muscle, with consequent coughing, wheezing, and shortness of breath.

See Adrenergic blocking agent and Bronchoconstriction

Bronchopulmonary segment

A bronchopulmonary segment is a portion of lung supplied by a specific segmental bronchus and its vessels.

See Adrenergic blocking agent and Bronchopulmonary segment

Butaxamine

Butaxamine (INN, also known as butoxamine) is a β2-selective beta blocker.

See Adrenergic blocking agent and Butaxamine

Calcium channel blocker

Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are a group of medications that disrupt the movement of calcium through calcium channels.

See Adrenergic blocking agent and Calcium channel blocker

Calcium in biology

Calcium ions (Ca2+) contribute to the physiology and biochemistry of organisms' cells.

See Adrenergic blocking agent and Calcium in biology

Cardiac output

In cardiac physiology, cardiac output (CO), also known as heart output and often denoted by the symbols Q, \dot Q, or \dot Q_, edited by Catherine E. Williamson, Phillip Bennett is the volumetric flow rate of the heart's pumping output: that is, the volume of blood being pumped by a single ventricle of the heart, per unit time (usually measured per minute).

See Adrenergic blocking agent and Cardiac output

Cardiac physiology

Cardiac physiology or heart function is the study of healthy, unimpaired function of the heart: involving blood flow; myocardium structure; the electrical conduction system of the heart; the cardiac cycle and cardiac output and how these interact and depend on one another.

See Adrenergic blocking agent and Cardiac physiology

Cardiovascular disease

Cardiovascular disease (CVD) is any disease involving the heart or blood vessels.

See Adrenergic blocking agent and Cardiovascular disease

Central nervous system

The central nervous system (CNS) is the part of the nervous system consisting primarily of the brain and spinal cord.

See Adrenergic blocking agent and Central nervous system

Chemical structure

A chemical structure of a molecule is a spatial arrangement of its atoms and their chemical bonds.

See Adrenergic blocking agent and Chemical structure

Chest pain

Chest pain is pain or discomfort in the chest, typically the front of the chest.

See Adrenergic blocking agent and Chest pain

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation.

See Adrenergic blocking agent and Chronic obstructive pulmonary disease

Ciliary muscle

The ciliary muscle is an intrinsic muscle of the eye formed as a ring of smooth muscleSchachar, Ronald A. (2012). "Anatomy and Physiology." (Chapter 4). in the eye's middle layer, uvea (vascular layer). It controls accommodation for viewing objects at varying distances and regulates the flow of aqueous humor into Schlemm's canal.

See Adrenergic blocking agent and Ciliary muscle

Confusion

In medicine, confusion is the quality or state of being bewildered or unclear.

See Adrenergic blocking agent and Confusion

Coronary circulation

Coronary circulation is the circulation of blood in the arteries and veins that supply the heart muscle (myocardium).

See Adrenergic blocking agent and Coronary circulation

Cramp

A cramp is a sudden, involuntary, painful skeletal muscle contraction or overshortening associated with electrical activity; while generally temporary and non-damaging, they can cause significant pain and a paralysis-like immobility of the affected muscle.

See Adrenergic blocking agent and Cramp

Cyclic adenosine monophosphate

Cyclic adenosine monophosphate (cAMP, cyclic AMP, or 3',5'-cyclic adenosine monophosphate) is a second messenger, or cellular signal occurring within cells, that is important in many biological processes.

See Adrenergic blocking agent and Cyclic adenosine monophosphate

Cytochrome P450

Cytochromes P450 (P450s or CYPs) are a superfamily of enzymes containing heme as a cofactor that mostly, but not exclusively, function as monooxygenases.

See Adrenergic blocking agent and Cytochrome P450

Diabetes

Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels.

See Adrenergic blocking agent and Diabetes

Diglyceride

A diglyceride, or diacylglycerol (DAG), is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages.

See Adrenergic blocking agent and Diglyceride

Diuretic

A diuretic is any substance that promotes diuresis, the increased production of urine.

See Adrenergic blocking agent and Diuretic

Dizziness

Dizziness is an imprecise term that can refer to a sense of disorientation in space, vertigo, or lightheadedness.

See Adrenergic blocking agent and Dizziness

Doxazosin

Doxazosin, sold under the brand names Cardura among others, is a medication used to treat symptoms of benign prostatic hyperplasia (enlarged prostate), hypertension (high blood pressure), and posttraumatic stress disorder (PTSD).

See Adrenergic blocking agent and Doxazosin

Dream

A dream is a succession of images, ideas, emotions, and sensations that usually occur involuntarily in the mind during certain stages of sleep.

See Adrenergic blocking agent and Dream

Dryness (medical)

Dryness is a medical condition in which there is local or more generalized decrease in normal lubrication of the skin or mucous membranes.

See Adrenergic blocking agent and Dryness (medical)

Edema

Edema (AmE), also spelled oedema (BrE), and also known as fluid retention, dropsy, hydropsy and swelling, is the build-up of fluid in the body's tissue.

See Adrenergic blocking agent and Edema

Erectile dysfunction

Erectile dysfunction (ED), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity.

See Adrenergic blocking agent and Erectile dysfunction

Extravasation is the leakage of a fluid out of its contained space into the surrounding the area, especially blood or blood cells from vessels.

See Adrenergic blocking agent and Extravasation

Eye

An eye is a sensory organ that allows an organism to perceive visual information.

See Adrenergic blocking agent and Eye

Fatigue

Fatigue describes a state of tiredness (which is not sleepiness), exhaustion or loss of energy.

See Adrenergic blocking agent and Fatigue

Fight-or-flight response

The fight-or-flight or the fight-flight-freeze-or-fawn (also called hyperarousal or the acute stress response) is a physiological reaction that occurs in response to a perceived harmful event, attack, or threat to survival. Adrenergic blocking agent and fight-or-flight response are sympathetic nervous system.

See Adrenergic blocking agent and Fight-or-flight response

First-dose phenomenon

The first-dose phenomenon is a sudden and severe fall in blood pressure that can occur when changing from a lying to a standing position the first time that an alpha blocker drug is used or when resuming the drug after many months off.

See Adrenergic blocking agent and First-dose phenomenon

Food and Drug Administration

The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.

See Adrenergic blocking agent and Food and Drug Administration

G protein-coupled receptor

G protein-coupled receptors (GPCRs), also known as seven-(pass)-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptors, and G protein-linked receptors (GPLR), form a large group of evolutionarily related proteins that are cell surface receptors that detect molecules outside the cell and activate cellular responses.

See Adrenergic blocking agent and G protein-coupled receptor

Glaucoma

Glaucoma is a group of eye diseases that lead to damage of the optic nerve, which transmits visual information from the eye to the brain.

See Adrenergic blocking agent and Glaucoma

Glucagon

Glucagon is a peptide hormone, produced by alpha cells of the pancreas.

See Adrenergic blocking agent and Glucagon

Glucuronidation

Glucuronidation is often involved in drug metabolism of substances such as drugs, pollutants, bilirubin, androgens, estrogens, mineralocorticoids, glucocorticoids, fatty acid derivatives, retinoids, and bile acids.

See Adrenergic blocking agent and Glucuronidation

Glucuronide

A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond.

See Adrenergic blocking agent and Glucuronide

Glycogenolysis

Glycogenolysis is the breakdown of glycogen (n) to glucose-1-phosphate and glycogen (n-1).

See Adrenergic blocking agent and Glycogenolysis

Gs alpha subunit

The Gs alpha subunit (Gαs, Gsα) is a subunit of the heterotrimeric G protein Gs that stimulates the cAMP-dependent pathway by activating adenylyl cyclase.

See Adrenergic blocking agent and Gs alpha subunit

Hallucination

A hallucination is a perception in the absence of an external stimulus that has the compelling sense of reality.

See Adrenergic blocking agent and Hallucination

Headache

Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck.

See Adrenergic blocking agent and Headache

Heart

The heart is a muscular organ found in most animals.

See Adrenergic blocking agent and Heart

Heart block

Heart block (HB) is a disorder in the heart's rhythm due to a fault in the natural pacemaker.

See Adrenergic blocking agent and Heart block

Heart failure

Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart's ability to fill with and pump blood.

See Adrenergic blocking agent and Heart failure

Heart rate

Heart rate is the frequency of the heartbeat measured by the number of contractions of the heart per minute (beats per minute, or bpm).

See Adrenergic blocking agent and Heart rate

Hyperaldosteronism

Hyperaldosteronism is a medical condition wherein too much aldosterone is produced.

See Adrenergic blocking agent and Hyperaldosteronism

Hypertension

Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated.

See Adrenergic blocking agent and Hypertension

Hypertensive crisis

Severely elevated blood pressure (equal to or greater than 180 mmHg systolic or 120 mmHg diastolic) is referred to as a hypertensive crisis (sometimes termed malignant or accelerated hypertension), due to the high risk of complications.

See Adrenergic blocking agent and Hypertensive crisis

Hypoglycemia

Hypoglycemia, also called low blood sugar, is a fall in blood sugar to levels below normal, typically below 70 mg/dL (3.9 mmol/L).

See Adrenergic blocking agent and Hypoglycemia

Hypotension

Hypotension, also known as low blood pressure, is a cardiovascular condition characterized by abnormally reduced blood pressure.

See Adrenergic blocking agent and Hypotension

Inositol trisphosphate

Inositol trisphosphate or inositol 1,4,5-trisphosphate abbreviated InsP3 or Ins3P or IP3 is an inositol phosphate signaling molecule.

See Adrenergic blocking agent and Inositol trisphosphate

Intravenous sodium bicarbonate

Intravenous sodium bicarbonate, also known as sodium hydrogen carbonate, is a medication primarily used to treat severe metabolic acidosis.

See Adrenergic blocking agent and Intravenous sodium bicarbonate

Iris (anatomy)

The iris (irides or irises) is a thin, annular structure in the eye in most mammals and birds, responsible for controlling the diameter and size of the pupil, and thus the amount of light reaching the retina.

See Adrenergic blocking agent and Iris (anatomy)

Iris dilator muscle

The iris dilator muscle (pupil dilator muscle, pupillary dilator, radial muscle of iris, radiating fibers), is a smooth muscle of the eye, running radially in the iris and therefore fit as a dilator.

See Adrenergic blocking agent and Iris dilator muscle

Ischemia

Ischemia or ischaemia is a restriction in blood supply to any tissue, muscle group, or organ of the body, causing a shortage of oxygen that is needed for cellular metabolism (to keep tissue alive).

See Adrenergic blocking agent and Ischemia

James Black (pharmacologist)

Sir James Whyte Black (14 June 1924 – 22 March 2010) was a Scottish physician and pharmacologist.

See Adrenergic blocking agent and James Black (pharmacologist)

Kidney

In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation.

See Adrenergic blocking agent and Kidney

Lipolysis

Lipolysis is the metabolic pathway through which lipid triglycerides are hydrolyzed into a glycerol and free fatty acids.

See Adrenergic blocking agent and Lipolysis

Lipophilicity

Lipophilicity (from Greek λίπος "fat" and φίλος "friendly") is the ability of a chemical compound to dissolve in fats, oils, lipids, and non-polar solvents such as hexane or toluene.

See Adrenergic blocking agent and Lipophilicity

Lisinopril

Lisinopril is a medication belonging to the drug class of angiotensin-converting enzyme (ACE) inhibitors and is used to treat hypertension (high blood pressure), heart failure, and heart attacks.

See Adrenergic blocking agent and Lisinopril

Local anesthesia

Local anesthesia is any technique to induce the absence of sensation in a specific part of the body, generally for the aim of inducing local analgesia, i.e. local insensitivity to pain, although other local senses may be affected as well.

See Adrenergic blocking agent and Local anesthesia

Medical uses of magnesium sulfate

Magnesium sulfate as a medication is used to treat and prevent low blood magnesium and seizures in women with eclampsia.

See Adrenergic blocking agent and Medical uses of magnesium sulfate

Mental state

A mental state, or a mental property, is a state of mind of a person.

See Adrenergic blocking agent and Mental state

Metabolism (from μεταβολή metabolē, "change") is the set of life-sustaining chemical reactions in organisms.

See Adrenergic blocking agent and Metabolism

In biochemistry, a metabolite is an intermediate or end product of metabolism.

See Adrenergic blocking agent and Metabolite

Metoprolol

Metoprolol, sold under the brand name Lopressor among others, is a medication used to treat high blood pressure, angina, and a number of conditions involving an abnormally fast heart rate.

See Adrenergic blocking agent and Metoprolol

Migraine

Migraine is a genetically influenced complex neurological disorder characterized by episodes of moderate-to-severe headache, most often unilateral and generally associated with nausea and light and sound sensitivity.

See Adrenergic blocking agent and Migraine

Miosis

Miosis, or myosis, is excessive constriction of the pupil.

See Adrenergic blocking agent and Miosis

Myocardial contractility

Myocardial contractility represents the innate ability of the heart muscle (cardiac muscle or myocardium) to contract.

See Adrenergic blocking agent and Myocardial contractility

Myocardial infarction

A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing infarction (tissue death) to the heart muscle.

See Adrenergic blocking agent and Myocardial infarction

Nausea

Nausea is a diffuse sensation of unease and discomfort, sometimes perceived as an urge to vomit.

See Adrenergic blocking agent and Nausea

Neurogenic bladder dysfunction

Neurogenic bladder dysfunction, often called by the shortened term neurogenic bladder, refers to urinary bladder problems due to disease or injury of the central nervous system or peripheral nerves involved in the control of urination.

See Adrenergic blocking agent and Neurogenic bladder dysfunction

Neurology

Neurology (from νεῦρον (neûron), "string, nerve" and the suffix -logia, "study of") is the branch of medicine dealing with the diagnosis and treatment of all categories of conditions and disease involving the nervous system, which comprises the brain, the spinal cord and the peripheral nerves.

See Adrenergic blocking agent and Neurology

Neurotransmitter

A neurotransmitter is a signaling molecule secreted by a neuron to affect another cell across a synapse.

See Adrenergic blocking agent and Neurotransmitter

Nightmare

A nightmare, also known as a bad dream, Retrieved 11 July 2016.

See Adrenergic blocking agent and Nightmare

Nitrovasodilator

A nitrovasodilator is a pharmaceutical agent that causes vasodilation (widening of blood vessels) by donation of nitric oxide (NO), and is mostly used for the treatment and prevention of angina pectoris.

See Adrenergic blocking agent and Nitrovasodilator

Nonsteroidal anti-inflammatory drug

Non-steroidal anti-inflammatory drugs (NSAID) are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever, and prevents blood clots.

See Adrenergic blocking agent and Nonsteroidal anti-inflammatory drug

Norepinephrine

Norepinephrine (NE), also called noradrenaline (NA) or noradrenalin, is an organic chemical in the catecholamine family that functions in the brain and body as a hormone, neurotransmitter and neuromodulator.

See Adrenergic blocking agent and Norepinephrine

Ocular hypertension

Ocular hypertension is the presence of elevated fluid pressure inside the eye (intraocular pressure), usually with no optic nerve damage or visual field loss.

See Adrenergic blocking agent and Ocular hypertension

Off-label use

Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

See Adrenergic blocking agent and Off-label use

Orthostatic hypotension

Orthostatic hypotension, also known as postural hypotension, is a medical condition wherein a person's blood pressure drops when standing up or sitting down.

See Adrenergic blocking agent and Orthostatic hypotension

Palpitations

Palpitations are perceived abnormalities of the heartbeat characterized by awareness of cardiac muscle contractions in the chest, which is further characterized by the hard, fast and/or irregular beatings of the heart.

See Adrenergic blocking agent and Palpitations

Parasympathetic nervous system

The parasympathetic nervous system (PSNS) is one of the three divisions of the autonomic nervous system, the others being the sympathetic nervous system and the enteric nervous system. Adrenergic blocking agent and parasympathetic nervous system are autonomic nervous system.

See Adrenergic blocking agent and Parasympathetic nervous system

Paroxysmal hypertension

Paroxysmal hypertension is episodic and volatile high blood pressure, which may be due to stress of any sort, or from a pheochromocytoma, a type of tumor involving the adrenal medulla.

See Adrenergic blocking agent and Paroxysmal hypertension

Perfusion

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue.

See Adrenergic blocking agent and Perfusion

Peripheral artery disease

Peripheral artery disease (PAD) is a vascular disorder that causes abnormal narrowing of arteries other than those that supply the heart or brain.

See Adrenergic blocking agent and Peripheral artery disease

Phenoxybenzamine

Phenoxybenzamine (PBZ, marketed under the trade names Dibenzyline and Dibenyline) is a non-selective, irreversible alpha blocker.

See Adrenergic blocking agent and Phenoxybenzamine

Phentolamine

Phentolamine, sold under the brand name Regitine among others, is a reversible nonselective α-adrenergic antagonist.

See Adrenergic blocking agent and Phentolamine

Pheochromocytoma

Pheochromocytoma is a rare tumor of the adrenal medulla composed of chromaffin cells and is part of the paraganglioma (PGL) family of tumors, being defined as an intra-adrenal PGL.

See Adrenergic blocking agent and Pheochromocytoma

Phosphodiesterase inhibitor

A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers, cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).

See Adrenergic blocking agent and Phosphodiesterase inhibitor

Phospholipase C

Phospholipase C (PLC) is a class of membrane-associated enzymes that cleave phospholipids just before the phosphate group (see figure).

See Adrenergic blocking agent and Phospholipase C

Post-traumatic stress disorder

Post-traumatic stress disorder (PTSD) is a mental and behavioral disorder that develops from experiencing a traumatic event, such as sexual assault, warfare, traffic collisions, child abuse, domestic violence, or other threats on a person's life or well-being.

See Adrenergic blocking agent and Post-traumatic stress disorder

Prazosin

Prazosin, sold under the brand name Minipress among others, is a medication used to treat high blood pressure, symptoms of an enlarged prostate, and nightmares related to post-traumatic stress disorder (PTSD).

See Adrenergic blocking agent and Prazosin

Priapism

Priapism is a condition in which a penis remains erect for hours in the absence of stimulation or after stimulation has ended.

See Adrenergic blocking agent and Priapism

Propranolol

Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors, as well to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks.

See Adrenergic blocking agent and Propranolol

Prostaglandin

Prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids that have diverse hormone-like effects in animals.

See Adrenergic blocking agent and Prostaglandin

Prostatitis

Prostatitis is an umbrella term for a variety of medical conditions that incorporate bacterial and non-bacterial origin illnesses in the pelvic region.

See Adrenergic blocking agent and Prostatitis

Protein kinase A

In cell biology, protein kinase A (PKA) is a family of serine-threonine kinase whose activity is dependent on cellular levels of cyclic AMP (cAMP).

See Adrenergic blocking agent and Protein kinase A

Raynaud syndrome

Raynaud syndrome, also known as Raynaud's phenomenon, is a medical condition in which the spasm of small arteries causes episodes of reduced blood flow to end arterioles.

See Adrenergic blocking agent and Raynaud syndrome

Renin

Renin (etymology and pronunciation), also known as an angiotensinogenase, is an aspartic protease protein and enzyme secreted by the kidneys that participates in the body's renin–angiotensin–aldosterone system (RAAS)—also known as the renin–angiotensin–aldosterone axis—that increases the volume of extracellular fluid (blood plasma, lymph and interstitial fluid) and causes arterial vasoconstriction.

See Adrenergic blocking agent and Renin

Sedation

Sedation is the reduction of irritability or agitation by administration of sedative drugs, generally to facilitate a medical procedure or diagnostic procedure.

See Adrenergic blocking agent and Sedation

Serotonin

Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.

See Adrenergic blocking agent and Serotonin

Short-term memory

Short-term memory (or "primary" or "active memory") is the capacity for holding a small amount of information in an active, readily available state for a short interval.

See Adrenergic blocking agent and Short-term memory

Skeletal muscle

Skeletal muscle (commonly referred to as muscle) is one of the three types of vertebrate muscle tissue, the other being cardiac muscle and smooth muscle.

See Adrenergic blocking agent and Skeletal muscle

Smooth muscle

Smooth (soft) muscle is one of the three major types of vertebrate muscle tissue, the other being skeletal and cardiac muscle.

See Adrenergic blocking agent and Smooth muscle

Somnolence

Somnolence (alternatively sleepiness or drowsiness) is a state of strong desire for sleep, or sleeping for unusually long periods (compare hypersomnia).

See Adrenergic blocking agent and Somnolence

Steroid

A steroid is an organic compound with four fused rings (designated A, B, C, and D) arranged in a specific molecular configuration.

See Adrenergic blocking agent and Steroid

Sympathetic nervous system

The sympathetic nervous system (SNS) is one of the three divisions of the autonomic nervous system, the others being the parasympathetic nervous system and the enteric nervous system. Adrenergic blocking agent and sympathetic nervous system are autonomic nervous system.

See Adrenergic blocking agent and Sympathetic nervous system

References

[1] https://en.wikipedia.org/wiki/Adrenergic_blocking_agent

, Chemical structure, Chest pain, Chronic obstructive pulmonary disease, Ciliary muscle, Confusion, Coronary circulation, Cramp, Cyclic adenosine monophosphate, Cytochrome P450, Diabetes, Diglyceride, Diuretic, Dizziness, Doxazosin, Dream, Dryness (medical), Edema, Erectile dysfunction, Extravasation, Eye, Fatigue, Fight-or-flight response, First-dose phenomenon, Food and Drug Administration, G protein-coupled receptor, Glaucoma, Glucagon, Glucuronidation, Glucuronide, Glycogenolysis, Gs alpha subunit, Hallucination, Headache, Heart, Heart block, Heart failure, Heart rate, Hyperaldosteronism, Hypertension, Hypertensive crisis, Hypoglycemia, Hypotension, Inositol trisphosphate, Intravenous sodium bicarbonate, Iris (anatomy), Iris dilator muscle, Ischemia, James Black (pharmacologist), Kidney, Lipolysis, Lipophilicity, Lisinopril, Local anesthesia, Medical uses of magnesium sulfate, Mental state, Metabolism, Metabolite, Metoprolol, Migraine, Miosis, Myocardial contractility, Myocardial infarction, Nausea, Neurogenic bladder dysfunction, Neurology, Neurotransmitter, Nightmare, Nitrovasodilator, Nonsteroidal anti-inflammatory drug, Norepinephrine, Ocular hypertension, Off-label use, Orthostatic hypotension, Palpitations, Parasympathetic nervous system, Paroxysmal hypertension, Perfusion, Peripheral artery disease, Phenoxybenzamine, Phentolamine, Pheochromocytoma, Phosphodiesterase inhibitor, Phospholipase C, Post-traumatic stress disorder, Prazosin, Priapism, Propranolol, Prostaglandin, Prostatitis, Protein kinase A, Raynaud syndrome, Renin, Sedation, Serotonin, Short-term memory, Skeletal muscle, Smooth muscle, Somnolence, Steroid, Sympathetic nervous system, Syncope (medicine), Tachycardia, Tamsulosin, Timolol, Tryptophan, Urinary incontinence, Vasoconstriction, Vasodilation, Vomiting, Weakness, Weight gain, Yohimbine, 5-HT receptor.

Adrenergic blocking agent, the Glossary

Table of Contents